Frontlight ResearchEarly access
Pancreatic cancer trials in United States
405 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleA Noninvasive and Screening miRNA Signature for Gastrointestinal Cancer
- Where
- Duarte
- Age
- 18 years and over
- People
- 1,000
- Run by
- City of Hope Medical Center
See details and how to joinNCT07224750 - Phase 1Taking peopleA Study of Sigvotatug Vedotin in Advanced Solid Tumors
- Where
- Anaheim, Anchorage, Babylon, Bonney Lake, Boston, Brooklyn, Calumet City, Chicago, Cleveland, Coon Rapids, Crown Point, Edmonds, Fairfax, Fairway, Fayetteville, Federal Way, Flossmoor, Fort Myers, Fort Wayne, Fullerton, Gig Harbor, Harvey, Hollywood, Houston, Indianapolis, Irving, Kansas City, Las Vegas, Los Alamitos, Los Angeles, Minneapolis, Nashville, New Hyde Park, New Lenox, Newton, New York, Oklahoma City, Olympia, Orlando, Orland Park, Overland Park, Patchogue, Pearland, Pembroke Pines, Port Jefferson Station, Portland, Puyallup, Riverhead, Rogers, Saint Paul, San Antonio, Santa Monica, Seattle, Shirley, Sioux Falls, Springdale, Springfield, Tacoma, The Bronx, Tinley Park, Torrance, Tyler, Webster, Westwood
- Age
- 18 years and over
- People
- 1,006 worldwide
- Run by
- Seagen, a wholly owned subsidiary of Pfizer
See details and how to joinNCT04389632 · EU 2023-508469-34-00 - Phase 1Taking peopleA Study of PT0511 in Participants With KRAS Mutated or Amplified Advanced Solid Tumors
- Where
- Boston, Fairfax, San Antonio, West Valley City
- Age
- 18 years and over
- People
- 210 worldwide
- Run by
- PAQ Therapeutics, Inc.
See details and how to joinNCT07300150 - Phase 1Taking peopleA First-in-Human Study to Evaluate Implantable Iontophoresis Chemotherapy Delivery Device With Gemcitabine Once Weekly or Twice Weekly in Participants With Pancreatic Cancer
- Where
- Ann Arbor, Morgantown
- Age
- 18 years and over
- People
- 12
- Run by
- Continuity Biosciences, LLC
See details and how to joinNCT07481383 - No phaseEnrolling by invitationProtocol to Permit the Acquisition of Circulating Tumor Material in Pancreatic Diseases
- Where
- Philadelphia
- Age
- 18 years and over
- People
- 100
- Run by
- Abramson Cancer Center at Penn Medicine
See details and how to joinNCT02471170 - No phaseTaking peopleEXoPERT EMERALD Clinical Study
- Where
- Albany, Baltimore, Honolulu, Lexington, Long Beach, Los Angeles, Louisville, The Bronx, Wappingers Falls
- Age
- 45 years and over
- People
- 1,400
- Run by
- EXoPERT
See details and how to joinNCT07186296 - No phaseTaking peopleIntegrated Cancer Repository for Cancer Research
- Where
- Aitkin, Alliance, Aurora, Bozeman, Brainerd, Canton, Council Bluffs, Daytona Beach, DeLand, Duluth, Fargo, Fayetteville, Fergus Falls, Fort Wayne, Glens Falls, Green Bay, Greenwood Village, Hastings, Holyoke, Kansas City, Liberty, Manchester, Minot, Norfolk, North Kansas City, North Platte, Omaha, Orange City, Overland Park, Palm Coast, Randallstown, Saint Joseph, Tallahassee, Utica, Waterloo, Westminster, Yorkville
- Age
- 19 years to 110 years
- People
- 999,999
- Run by
- University of Nebraska
See details and how to joinNCT02012699 - Phase 1Taking peopleIntra-tumoral Mitazalimab (CD40 Antibody) With Irreversible Electroporation (IRE) in Locally Advanced Pancreas Cancer
- Where
- La Jolla
- Age
- 18 years and over
- People
- 18
- Run by
- University of California, San Diego
See details and how to joinNCT06205849 - Phase 4Taking peopleSurgical Debulking Prior to Peptide Receptor Radionuclide Therapy in Well Differentiated Gastroenteropancreatic Neuroendocrine Tumors
- Where
- Nashville
- Age
- 18 years and over
- People
- 6
- Run by
- Vanderbilt-Ingram Cancer Center
See details and how to joinNCT06016855 - No phaseTaking peoplePilot Study to Evaluate Targeted Physical Activity Among Pancreatic Cancer Patients Receiving Neoadjuvant Chemotherapy
- Where
- Chicago
- Age
- 18 years and over
- People
- 25
- Run by
- University of Illinois Chicago
See details and how to joinNCT07647250 - Phase 1Taking peopleA Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies
- Where
- Denver, Los Angeles, Nashville
- Age
- 18 years and over
- People
- 134
- Run by
- RasCal Therapeutics, Inc.
See details and how to joinNCT04678648 - Phase 1Taking peopleStudy to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
- Where
- Austin, Chicago, Duarte, Durham, Fairfax, Fort Wayne, Grand Rapids, Houston, Huntersville, Indianapolis, Irvine, Irving, Los Angeles, Louisville, Minneapolis, Omaha, San Antonio, West Valley City
- Age
- 18 years and over
- People
- 694 worldwide
- Run by
- AbbVie
See details and how to joinNCT05005403 - No phaseTaking peopleEvaluating the Prognostic Capability of ctDNA as a Biomarker in Pancreatic Cancer Patients Undergoing Neoadjuvant Chemotherapy
- Where
- DeKalb, Geneva, Warrenville
- Age
- 18 years and over
- People
- 500
- Run by
- Northwestern University
See details and how to joinNCT04616131 - No phaseTaking peopleFamilial Investigations of Childhood Cancer Predisposition
- Where
- Memphis
- People
- 1,500
- Run by
- St. Jude Children's Research Hospital
See details and how to joinNCT03050268 - Phase 2/3Not yet taking people in United StatesStudy to Evaluate the Diagnostic Performance of GEH300079 (68Ga) Injection PET/CT for Detection of PC in Patients With Colorectal, Gastric, Ovarian, or Pancreatic Cancers (PERISCOPE)
- Where
- Grand Rapids
- Age
- 18 years and over
- People
- 175 worldwide
- Run by
- GE Healthcare
See details and how to joinNCT07219238 · EU 2024-519384-18-00 - Phase 1/2Taking peopleStudy of EGFRBi Armed Fresh PBMC in Metastatic or Unresectable Pancreatic Cancer
- Where
- Charlottesville
- Age
- 18 years and over
- People
- 23
- Run by
- University of Virginia
See details and how to joinNCT06479239 - Phase 1Not yet taking people in United StatesA Study of CLSP 5282 in HLA-A*03:01 Positive Adult Patients With Solid Tumors (SENTINEL-101)
- Where
- Dallas, Durham, Nashville, Philadelphia
- Age
- 18 years and over
- People
- 140
- Run by
- Clasp Therapeutics, Inc.
See details and how to joinNCT07650357 - No phaseTaking peopleA Tailored, Web-based Program (COMPASS) to Improve Exercise and Dietary Changes in Stage I-III Pancreatic Cancer Patients Receiving Neoadjuvant Chemotherapy
- Where
- Portland
- Age
- 18 years and over
- People
- 30
- Run by
- OHSU Knight Cancer Institute
See details and how to joinNCT07651358 - No phaseTaking peopleUltra-High Resolution Optical Coherence Tomography in Detecting Micrometer Sized Early Stage Pancreatic Cancer in Participants With Pancreatic Cancer
- Where
- Columbus
- Age
- 18 years and over
- People
- 75
- Run by
- Ohio State University Comprehensive Cancer Center
See details and how to joinNCT03711890 - Early phase 1Taking peopleLidocaine Infusion in Pancreatic Cancer
- Where
- Chicago
- Age
- 18 years and over
- People
- 46
- Run by
- University of Illinois Chicago
See details and how to joinNCT04048278 - Phase 1Taking peopleMEM-288 Oncolytic Virus Alone and in Combination With Standard of Care Therapy in Advanced Solid Tumors
- Where
- Durham, Tampa
- Age
- 18 years and over
- People
- 40
- Run by
- Memgen, Inc.
See details and how to joinNCT05076760 - Phase 2Taking peopleMaintenance Combinatorial Myeloid Immunotherapy for Unresectable Pancreatic Cancer
- Where
- Philadelphia
- Age
- 18 years and over
- People
- 100
- Run by
- University of Pennsylvania
See details and how to joinNCT07199764 - No phaseTaking peopleIncreasing Germline Genetic Testing for Patients With Cancer
- Where
- Chicago, Danville, Decatur, Durham, Indianapolis, Los Angeles, Nashville, Orlando, Salisbury, Salt Lake City
- People
- 1,000
- Run by
- Josh Peterson
See details and how to joinNCT07307664 - Phase 1Taking peopleStudy of CX-5461 in Patients With Solid Tumours and BRCA1/2, PALB2 or Homologous Recombination Deficiency (HRD) Mutation
- Where
- Boston, Columbus, New York, Pittsburgh, Santa Monica, Tampa
- Age
- 18 years and over
- People
- 52 worldwide
- Run by
- Senhwa Biosciences, Inc.
See details and how to joinNCT04890613 - Phase 1Taking peopleAutologous CAR-T Cells Targeting B7-H3 in PDAC
- Where
- Chapel Hill
- Age
- 18 years and over
- People
- 27
- Run by
- UNC Lineberger Comprehensive Cancer Center
See details and how to joinNCT06158139